Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Ruth Keogh is a Professor of Biostatistics and Epidemiology at the London School of Hygiene & Tropical Medicine (LSHTM), affiliated with the Medical Statistics Department within the Faculty of Epidemiology and Population Health. She is Co-Director of the Centre for Data and Statistical Science for Health (DASH) and serves as Departmental Research Degrees Coordinator. Her academic career has spanned roles from Lecturer (2012–2015) to Associate Professor (2015–2019) before attaining her current rank in 2019. Keogh holds advanced degrees including a DPhil in Medical Statistics/Epidemiology (University of Oxford, 2007), MSc in Applied Statistics (Oxford, 2003), and BSc in Mathematics and Statistics (University of Edinburgh, 2002). Her research focuses on causal inference, clinical trial emulation using real-world data, and applications in cystic fibrosis, infectious diseases, and public health. She leads projects on lung function trajectories, vaccine efficacy, and healthcare policy analysis. Her work integrates biostatistical methods with epidemiological studies, emphasizing rigorous analysis of observational data to inform clinical decisions. Notable areas include evaluating antibiotic treatments for cystic fibrosis patients, assessing diagnostic test accuracy for dengue and leptospirosis, and modeling vaccine effectiveness during the COVID-19 pandemic. She teaches courses in survival analysis, electronic health records, and health data science at LSHTM. Keogh has held leadership roles in the International Biometric Society and the STRATOS Initiative, and she has delivered keynote addresses at international conferences on trial emulation and biostatistical methods. Her contributions bridge methodological innovation and practical health challenges, with over 190 publications and active engagement in global health research networks.
Gabriela Minigo serves as an Honorary Fellow in Global and Tropical Health and Associate Dean - Learning and Teaching within the Faculty of Health. Her academic profile demonstrates active engagement in malaria immunology research with a recent expansion into circadian rhythm and metabolic health investigations. Dr. Minigo completed her PhD at the University of Melbourne (awarded March 31, 2007) and earned a Master of Clinical Epidemiology from the University of Newcastle (awarded December 8, 2017). Her educational background provides a strong foundation in both basic science and clinical epidemiology. Her primary research focuses on immunological responses to malaria, with particular expertise in T follicular helper cells, dendritic cell function, and regulatory T cells in Plasmodium falciparum and Plasmodium vivax infections. Analysis of her research fingerprint reveals significant contributions to Plasmodium falciparum Immunology and Microbiology (100%), Dendritic Cell Immunology and Microbiology (45%), Regulatory T Cell Immunology and Microbiology (38%), and other related fields. In recent years, she has expanded her research to investigate the relationship between photoperiod, circadian rhythm, and metabolic health, as evidenced by her 2024 publications on these topics. Dr. Minigo's scholarly output shows an evolving research trajectory from fundamental malaria immunology toward interdisciplinary investigations connecting circadian biology with metabolic health. Her recent publications (2022-2024) demonstrate continued strong contributions to malaria immunology while incorporating new dimensions related to light exposure, sleep patterns, and glucose control. She has secured research funding for multiple projects including 'Rainmaker start up- Does exposure to artificial light alter circadian rhythm and glucose control in Australian adults? A pilot study' (2023-2026) where she serves as Co-Investigator, and 'Effect of Extended Photoperiod Exposure on Circadian Rhythm and Glucose Control' (2024-present) where she is Principal Investigator. Previously, she contributed as Chief Investigator C to 'Manipulating T follicular helper cells to improve human malaria vaccines' (2020-2023). As Associate Dean for Learning and Teaching, Dr. Minigo holds significant educational leadership responsibilities within the Faculty of Health. She is registered to supervise postgraduate research, indicating her active role in mentoring graduate students in immunology and tropical medicine research.
Justin Milner, PhD, serves as Assistant Professor in the Department of Microbiology and Immunology at the University of North Carolina at Chapel Hill School of Medicine and is a member of the UNC Lineberger Comprehensive Cancer Center. His research develops novel approaches to enhance cancer immunotherapies through multi-omics and bioengineering techniques. Education: Postdoctoral Fellowship, UCSD PhD, UNC Chapel-Hill BS, UNC Chapel-Hill Dr. Milner's lab investigates molecular drivers of T cell differentiation and function within tumor microenvironments, utilizing cutting-edge genomics, bioengineering, and computational immunology. His work focuses on reprogramming T cell activity to overcome immunotherapy resistance in cancers, with particular emphasis on epigenetic regulation and metabolic adaptations of tumor-infiltrating lymphocytes. Recent projects explore hydrogel-based delivery systems for immunotherapeutics and transcriptional networks governing T cell exhaustion. Analysis of his 15 most recent publications reveals dominant themes in cancer immunotherapy enhancement, particularly through T cell engineering (7/15 articles), tumor microenvironment modulation (5/15), and computational approaches to T cell biology (3/15). Key methodologies include single-cell multi-omics, in vivo screening, and biomaterial-based drug delivery systems targeting solid tumors. Scientific Awards: NIH NCI K99/R00 Pathway to Independence Award V Foundation Scholar Award Lung Cancer Initiative Career Development Award UNC Lineberger Innovation Award Multiple institutional pilot awards including Hirschberg Foundation and Mary Kay Ash Awards Dr. Milner currently advises three graduate students and multiple postdoctoral researchers while leading an NIH-funded R01 project ($2.79 million) investigating epigenetic regulation of T cell exhaustion. His lab maintains active collaborations across computational medicine and pancreatic cancer research programs at UNC. The Milner Lab operates within the UNC Lineberger Comprehensive Cancer Center, utilizing core facilities for single-cell genomics, murine tumor modeling, and bioengineering. Current team includes seven researchers focused on T cell reprogramming strategies for solid tumor immunotherapy.
Douglas Slobod, MD, FRCPC serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site, affiliated with the Translational Research in Respiratory Diseases Program within the Centre for Outcomes Research and Evaluation (CORE). He maintains dual roles as both a research scientist and clinical intensivist in the Critical Care Medicine Program at the McGill University Health Centre. Dr. Slobod's research program centers on cardiopulmonary interactions in critically ill patients, with particular emphasis on how mechanical ventilation impacts right ventricular function. His work spans physiological investigations of lung injury mechanisms and clinical development of personalized respiratory support strategies for patients with acute respiratory failure. This research has significant implications for optimizing mechanical ventilation in acute respiratory distress syndrome (ARDS) while minimizing cardiovascular compromise. Analysis of his publication record reveals a consistent trajectory of high-impact research in critical care physiology. Recent work demonstrates growing sophistication in monitoring techniques (including electrical impedance tomography and esophageal pressure monitoring) and a shift toward personalized ventilation approaches. His publications frequently address the complex interplay between respiratory mechanics and cardiovascular function, with particular attention to right ventricular performance during different ventilation strategies. Dr. Slobod maintains an active collaborative network with researchers across North America and Europe, contributing to both clinical trials and physiological investigations that address fundamental questions in mechanical ventilation. His work appears in premier journals including the American Journal of Respiratory and Critical Care Medicine, Critical Care, and Intensive Care Medicine. As a clinician-scientist, Dr. Slobod exemplifies the translational research model, directly connecting physiological insights from the laboratory to clinical practice at the bedside. His ongoing research continues to refine our understanding of how to optimize respiratory support while preserving cardiovascular function in critically ill patients.
Dr. F. Jerry Reen serves as a Senior Lecturer and Principal Investigator in the School of Microbiology at University College Cork (UCC), Ireland. With over two decades of academic experience since joining UCC's Department of Microbiology in 2002, he has established himself as a leading researcher in microbial communication systems and host-pathogen interactions. His research group operates within the BIOMERIT Research Centre, and he maintains active collaborations across multiple institutions in Ireland and internationally. Dr. Reen earned his BSc in Biochemistry at the National University of Ireland Galway (NUIG), followed by a PhD in the Molecular GlycoBiotechnology Group at NUIG, supported by an Enterprise Ireland Scholarship and an NUI Teaching Fellowship. His academic journey includes a postdoctoral position in the lab of Dr. E. Fidelma Boyd at UCC, during which he was a visiting scientist at the Sidney Kimmel Cancer Center in San Diego and received an IRCSET Postdoctoral Fellowship for bacteriophage-host interactions research. Dr. Reen's research focuses on deciphering communication systems underpinning polymicrobial-host interactions for human and ecosystem health, with particular emphasis on small molecule signaling in microbial communities. His work bridges fundamental microbiology with translational applications, targeting antimicrobial resistance through chemico-biological therapeutics and developing sustainable pharmaceutical production methods using marine biocatalysts. His research has evolved from early work on Vibrio species to current investigations of Pseudomonas aeruginosa signaling systems, bile acid interactions in cystic fibrosis, and marine enzyme applications in green chemistry. His laboratory's publication record demonstrates consistent productivity with over 80 peer-reviewed papers (h-index 26), spanning from foundational studies on LysR-type transcriptional regulators to recent innovations in virtual reality educational tools. The research trajectory reveals an expanding scope from molecular microbiology to systems-level understanding of microbial communities, with increasing emphasis on sustainable solutions for the pharmaceutical industry. Bronze LEAF Award (2022) - Green Campus University College Cork The Disciplinary Excellence in Learning, Teaching and Assessment (DELTA) Award (2021) - National Forum for the Enhancement of Teaching and Learning Purdy-Lucey UCC Life Sciences Invention of the Year 2015 (2016) Best Poster Exhibition (2012) - Royal Irish Academy National Researcher of the Year, Silver Medal (2011) - Roche BioSciences Researcher of the Year, Gold Medal (2011) - Roche Dr. Reen has successfully secured significant research funding from multiple sources including Science Foundation Ireland (SFI), Health Research Board (HRB), Enterprise Ireland, and Irish Research Council. His current projects include 'BioBloc' enhanced Contact LEns solutioNS (BBCLENS), HEACOVID19, SSPC3 Pharm5, and investigations into novel macrolides for cystic fibrosis management. He has mentored numerous graduate students, including Stephanie Flynn (PhD, 2019), Noelle McCarthy (PhD, 2009), and David Woods (MSc, 2008), with two doctoral students currently completing their research. His educational innovations, particularly student-partnered virtual reality simulations, have transformed how challenging molecular concepts are taught. Dr. Reen leads an interdisciplinary research group that combines microbiology, chemistry, bioinformatics, and education technology. His team collaborates with internal UCC colleagues including Dr. Gerard McGlacken and Prof. Anita Maguire, as well as external partners from institutions like the University of Warwick, Medical University of Graz, and University de Porto. The laboratory maintains strong connections with clinical researchers studying cystic fibrosis and has developed novel approaches for detecting bacterial signaling molecules using boron-doped diamond electrodes.
Elizabeth Brainerd is the Robert P. Brown Professor of Biology and Professor of Medical Science in the Department of Ecology and Evolutionary Biology at Brown University. She has been a leading figure in vertebrate biomechanics and evolutionary morphology since joining Brown in 2005, where she directs the Keck XROMM Core Facility. Previously, she served as Assistant Professor (1994-1999) and Associate Professor (2000-2005) at the University of Massachusetts Amherst. Her research focuses on biomechanics and evolutionary morphology, combining anatomical studies with engineering principles to understand animal movement. Brainerd is a pioneer of X-ray Reconstruction of Moving Morphology (XROMM) technology, which enables 3D visualization of skeletal movement in living animals. Her work spans diverse vertebrate groups including fish, amphibians, reptiles, birds, and mammals, with applications to feeding, breathing, and locomotion mechanics. Brainerd's research has been consistently supported by major NSF grants, including the development of microXROMM for high-resolution imaging of small animals. Her publications reveal a trajectory from foundational work on breathing mechanics to innovative applications of XROMM technology across multiple vertebrate systems, particularly in suction feeding mechanics and skeletal kinematics. Her scientific recognition includes: Fellow of the American Association for the Advancement of Science (2004) Distinguished Research Achievement Award from Brown University (2019) Fellow of the American Association for Anatomy (2020) Joseph S. Nelson Lifetime Achievement Award in Ichthyology (2021) Bidder Prize Lecture from the Society for Experimental Biology (2023) Brainerd has mentored 7 doctoral students and 5 MS students to completion, plus over 50 undergraduate researchers. She has served as President of both the International Society of Vertebrate Morphology (2016-2019) and the Society for Integrative and Comparative Biology (2019-2021). Her teaching includes undergraduate courses in Comparative Anatomy, Comparative Physiology, and Human Physiology, graduate courses in Muscle Architecture and Biomechanics, and medical education in Human Anatomy.
Michael S. Wolin, Ph.D., is a distinguished Professor of Physiology at the School of Medicine, New York Medical College (NYMC). With a career spanning several decades, Dr. Wolin has established himself as a leading researcher in vascular physiology, redox biology, and pulmonary hypertension. His work began with groundbreaking research on nitric oxide signaling as a postdoctoral fellow with Lou Ignarro at Tulane University, contributing to aspects of research that led to Ignarro's 1998 Nobel Prize in Physiology and Medicine. Dr. Wolin's research interests focus on oxidative stress signaling , pulmonary hypertension , vascular physiology , redox biology , nitric oxide signaling , and mitochondrial function . His NIH-funded laboratory at NYMC has made significant contributions to understanding how cellular regulatory systems—including mitochondrial function, oxidases, ROS metabolizing enzymes, and cellular redox control systems—function in physiological processes and pathophysiological conditions. His work has particularly advanced our understanding of oxygen sensing mechanisms, hypoxic pulmonary vasoconstriction, and the role of hydrogen peroxide as a signaling molecule. Dr. Wolin's recent publications (2019-2025) demonstrate continued research productivity with significant contributions to understanding placental development in maternal undernourishment, pulmonary vascular function, oxidative stress mechanisms in hypertension, and the role of various signaling molecules in cardiovascular disease progression. His work shows a consistent focus on the interplay between redox signaling, mitochondrial function, and vascular pathophysiology. Notable awards and honors include: Distinguished Scientist Award – American Chemical Society, Westchester Section (2010) Outstanding Faculty Award – Graduate Student Association of Basic Medical Sciences at NYMC (2009) Robert M. Berne – Distinguished Lectureship Awardee – American Physiological Society (2008) Merit Award – National Heart, Lung & Blood Institute, NIH (1995) Dr. Wolin has maintained significant editorial and service roles, including serving as Chair of the Integrative Vascular Physiology Pathology NIH Study Section (2021-2023), Consulting Editor for the American Journal of Physiology: Heart & Circulatory Physiology (2011-2018), and as a Fellow of the American Heart Association since 2001. His teaching responsibilities at NYMC include directing multiple physiology courses and mentoring graduate students through thesis research.
Jason Shahin is an Assistant Professor at the Department of Medicine , Faculty of Medicine and Health Sciences , McGill University . He serves as an Investigator at the Research Institute of the McGill University Health Centre (RI-MUHC) , specifically within the Translational Research in Respiratory Diseases Program . His academic and clinical work bridges critical care medicine and respiratory medicine at the McGill University Health Centre (MUHC) . Research Focus: Dr. Shahin specializes in risk prediction in intensive care units (ICU) , with particular emphasis on prediction tools for complex populations , including the chronic critically ill and potential organ donors . His work integrates clinical data science with translational approaches to improve ICU outcomes. Article Trends: His publications span critical care medicine , sepsis , mechanical ventilation , and organ donation . Recent studies focus on machine learning applications , probiotics in infection prevention , and blood conservation strategies in ICU settings. Key Collaborations: He contributes to large-scale trials like the LOVIT , PROSPECT , and FORECAST studies, collaborating with networks such as the Canadian Critical Care Trials Group and REVA Network .
David M. Markovitz is a tenured Professor in the Department of Internal Medicine at the University of Michigan Medical School. He has maintained continuous faculty appointments at the University since 1988, progressing from Assistant Professor (1988-1994) to Associate Professor with tenure (1994-2002) and ultimately to his current Professor position (2002-present). Dr. Markovitz leads a multidisciplinary research team comprising four additional faculty members, postdoctoral fellows, PhD students, MD/PhD students, medical students, physicians, public health students, and undergraduates. Dr. Markovitz's research program spans several interconnected domains in molecular medicine. His laboratory employs diverse methodologies including NMR, crystallography, molecular dynamics modeling, glycoclusters, next-generation sequencing, bioinformatics, and animal models to investigate viral pathogenesis and develop novel therapeutic approaches. His work has produced 92 publications and resulted in significant discoveries across multiple fields. The publication record reveals several major research trajectories: investigations into HIV transcription mechanisms; characterization of the DEK protein's role in cancer and juvenile arthritis; discovery of vimentin as a secreted inflammatory factor; exploration of human endogenous retroviruses (HERVs) in disease pathogenesis; and development of engineered lectins as broad-spectrum antiviral agents. His most notable contribution involves engineering banana lectin (BanLec) through a single amino acid mutation (H84T) that eliminates mitogenicity while preserving antiviral activity against HIV, hepatitis C, influenza, and coronaviruses including SARS and MERS. Dr. Markovitz has received numerous prestigious awards including the Burroughs Wellcome Clinical Scientist Award (2003), Association of American Physicians membership (2004), and a Transformative R01 from the NIH Office of the Director (2009). National Cancer Institute – Clinical Investigator Award (1990) Life and Health Insurance Medical Research Fund Scholar (1991) American Society for Clinical Investigation (1997) Burroughs Wellcome Clinical Scientist Award (2003) Association of American Physicians (2004) Transformative R01, NIH (2009) American Clinical and Climatological Association (2012) His current research portfolio demonstrates strong funding support across multiple domains. As Principal Investigator, he leads projects including DEK-targeted therapy for juvenile arthritis (Rheumatology Research Foundation), development of H84T BanLec for Ebola/Marburg treatment (DTRA), and lectin-based lung cancer therapy (UM Mi-Kickstart). As Co-PI, he contributes to NIH-funded research on DEK in hematopoiesis and international collaborations studying HERVs in human disease. His mentorship extends to numerous doctoral students, postdocs, and medical trainees who have gone on to independent research careers. Dr. Markovitz directs a vibrant research ecosystem that includes faculty collaborators Rafael Contreras, Scott Gitlin, and Mark Kaplan. His laboratory maintains extensive collaborations across the University of Michigan and with international partners. The research program bridges basic science discoveries with translational applications, particularly in developing novel therapeutics for viral diseases, autoimmune conditions, and cancer. His work on DEK aptamers and engineered lectins represents promising pathways toward clinical applications in inflammation and infectious disease.
Dharanidhar Dang serves as Assistant Professor in the Department of Computer Engineering at the College of AI, Cyber and Computing, The University of Texas at San Antonio (UTSA), where he advances hardware-centric artificial intelligence solutions through photonic and memristor technologies. Education Ph.D., Texas A&M University His research program bridges hardware innovation and biomedical applications, with primary focus on photonic computing architectures for real-time AI acceleration and memristor-based neuromorphic systems. He investigates critical challenges in hardware reliability (particularly degradation in memristor crossbars), energy efficiency in photonic accelerators, and co-design methodologies that optimize both algorithms and physical implementations. His biomedical work applies machine learning to macrophage biology, identifying predictive signatures for inflammatory diseases through computational immunology approaches. Analysis of his 2020-2025 publications reveals three dominant research trajectories: 1) Silicon photonic accelerators (P-ReTI, P-ReTiNA, SOFTONIC) targeting real-time and energy-efficient AI, 2) Memristor reliability frameworks addressing aging effects in deep learning hardware, and 3) Translational biomedical applications where machine learning deciphers macrophage behavior in inflammatory bowel disease and preterm infant lung conditions. This tripartite focus demonstrates exceptional versatility across hardware engineering and life sciences.
Dr. Zihang Lu is an Assistant Professor in the Department of Public Health Sciences at Queen’s University, affiliated with the School of Medicine and Faculty of Health Sciences. He holds a PhD and MSc in Biostatistics from the University of Toronto (2020 and 2013) and a BSc in Biostatistics from Southern Medical University (2012). His research focuses on developing novel statistical and machine learning methods for complex data analysis, with applications in clinical and epidemiological studies, particularly in asthma, obesity, sleep, pain, and cancer research. He collaborates with clinicians to address statistical challenges in longitudinal and functional data analysis, Bayesian modeling, and integrative clustering. Education : PhD in Biostatistics, University of Toronto (2020) MSc in Biostatistics, University of Toronto (2013) BSc in Biostatistics, Southern Medical University (2012) Research Interests : Bayesian data analysis and variable selection Longitudinal and functional data clustering High-dimensional data integration Statistical methods for disease subtyping Design and analysis of observational studies Advising & Grants : Current advisees: Caroline Lee (MSc 2022), Veronique Rowley (2021), Zhiwen Tan (PhD 2022), Mojtaba Ahmadiankalati (MSc 2021) Recruiting CANSSI Distinguished Post-Doctoral Fellow for Bayesian methods in longitudinal health data analysis Accepting MSc/PhD students for 2023 Labs & Teams : His team focuses on statistical methodology development and clinical collaborations, with active projects in pediatric lung function (e.g., the CHILD Cohort Study) and chronic disease management.
Erika Garcia, PhD, MPH is an Assistant Professor in the Division of Environmental Health at the Department of Population and Public Health Sciences, Keck School of Medicine of USC. Her work focuses on understanding how ambient environmental exposures influence human disease development, particularly through advanced causal inference methods. Key research areas include early-life air pollution effects on pediatric health (asthma, lung function, metabolic outcomes) and climate-driven exposures like extreme heat. Education: PhD in Environmental Health Sciences, UC Berkeley MPH in Environmental Health Sciences, UC Berkeley Research Interests: Climate change health impacts: heat waves, air pollution, and associated mortality/morbidity Environmental justice: disparities in pollution exposure and health outcomes Exposure mixtures: synergistic effects of chemical pollutants Epigenetic biomarkers of environmental exposures Recent Article Trends: Focus on methodological innovations in exposure assessment, policy-driven intervention modeling, and translational research linking environmental exposures to chronic disease pathways. Recent work emphasizes population-level vulnerability analysis and actionable solutions for disadvantaged communities. Advising/Grants: Active in mentoring interdisciplinary teams but specific grant details not highlighted in current text.
Alvar Agusti is a Full Professor of Medicine at the University of Barcelona, Spain, since 2020. His career spans leadership roles including Chair of the Board of Directors at the Global Initiative for Obstructive Lung Disease (GOLD) and former Director of the Respiratory Institute at Hospital Clinic, Barcelona (2009–2021). He pioneered the National Spanish Network of Excellence in Respiratory Research (CIBERES) from 2003 to 2011. MD (1979) and PhD (1985) in Medicine, University of Barcelona Fogarty Scholar (NIH) at the University of Chicago (1989–1991) His research focuses on chronic airway diseases (COPD, asthma), lung function trajectories, immune senescence, systems medicine, and organ interactions (e.g., hepato-pulmonary syndrome). Recent work explores COPD comorbidities, biomarkers, and long-term outcomes in respiratory disorders. His 2021 publications span COPD, asthma, lung function phenotypes, and cross-disciplinary themes like epigenetics , clinical trials , and COVID-19 comorbidities . Key contributions include stratification of respiratory diseases and biomarker discovery in cohorts like ECLIPSE and NOVELTY. Scientific accolades include membership in the Royal National Academy of Medicine of Catalunya (2021), Honorary Fellow of the European Respiratory Society (2018), and the Lilly Foundation award for clinical research (2018). He has delivered 493 invited lectures and authored 552 publications with an h-index of 95.
Iva Filipovic serves as a Research Specialist in the Department of Laboratory Medicine, Division of Clinical Microbiology at Karolinska Institutet since 2025, following her Postdoctoral Research Fellowship (2019-2025) at the Department of Medicine Huddinge, Center for Infectious Medicine. She contributes to The Systems Virology Lab under Ujjwal Neogi, focusing on translational immunology in medical contexts. Her educational background includes: PhD in Physiology, Development and Neuroscience (Reproductive Immunology), University of Cambridge (2019) MSc in Immunology, Imperial College London (2015) BSc in Molecular Biology with Physiology, University of Belgrade (2014) Her research integrates tissue-resident immunology with systems approaches, examining innate lymphocytes in reproductive health, infectious diseases, and cancer. She employs advanced methodologies including RNA-Seq, single-cell analysis, and 29-color flow cytometry to investigate immune mechanisms in endometrial tissue, liver fibrosis, and viral pathogenesis. Current work emphasizes translational applications in sepsis, cholangiocarcinoma, and SARS-CoV-2 immunity. Analysis of her 15 most recent publications (2018-2025) reveals dominant themes in mucosal immunology, with significant contributions to understanding MAIT cells in sepsis, NK cell dynamics in reproduction, and immune biomarkers in cancer. Her work consistently bridges basic immunology with clinical applications through multi-omics approaches and large-scale collaborative studies like the Karolinska KI/K COVID-19 immune atlas. She actively participates in The Systems Virology Lab, contributing to Karolinska's infectious disease research infrastructure. Her technical expertise in high-dimensional immune profiling supports collaborative projects across virology, hepatology, and oncology research groups at Karolinska Institutet.
